Coronary artery spasm induced by capecitabine

Journal of Cardiovascular Medicine

Volumn 7, Issue 2, 2006, Pages 136-138

  Sestito, Alfonso ^a   Sgueglia, Gregory Angelo ^a   Pozzo, Carmelo ^a   Cassano, Alessandra ^a   Barone, Carlo ^a   Crea, Filippo ^a   Lanza, Gaetano Antonio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Capacitabine; Coronary spasm; Variant angina

Indexed keywords

ACETYLSALICYLIC ACID; CAPECITABINE; CYCLOPHOSPHAMIDE; DILTIAZEM; FLUOROURACIL; GLYCERYL TRINITRATE; METHOTREXATE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER RELAPSE; CARDIOVASCULAR RISK; CASE REPORT; COLORECTAL CANCER; CORONARY ARTERY SPASM; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HUMAN; RISK FACTOR; ST SEGMENT ELEVATION; ANGINA PECTORIS; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; PAGET NIPPLE DISEASE; TUMOR RECURRENCE;

ADULT; ANGINA PECTORIS; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CORONARY VASOSPASM; DEOXYCYTIDINE; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL;

EID: 33646832009     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000199785.94760.50     Document Type: Article

References (12)

1. Dooley M, Goa KL. Capecitabine. Drugs 1999; 58:69-76.
2. Luwaert RJ, Descamps O, Majoist F, Chaudron JM, Beauduin M. Coronary artery spasm induced by 5-fluorouracil. Eur Heart J 1991; 12:468-470.
3. Lestuzzi C, Viel E, Picano E, Meneguzzo N. Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil. Am J Med 2001; 111:316-318.
4. Schnetzler B, Popola N, Collao Lamb C, Sappino AP. Coronary spasm induced by capecitabine. Ann Oncol 2001; 12:723-724.
5. Bertolini A, Fumano M, Fusco O, Muffatti A, Scarinci A, Pontiggia G, Scopelliti M. Acute cardiotoxicity during capecitabine treatment: a case report. Tumori 2001; 87:200-206.
6. Desrame J, Bronstein JA, Thiolet C, Bredin C, Ceccaldi B, Vergeau B, Farret O. Accident coronarien après prise de cape' citabine. Gastroenterol Clin Biol 2001; 25:829-830.
7. Frickhofen N, Beck FJ, Jung B, Fuhr HG, Andrash H, Sigmund M. Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. Ann Oncol 2002; 13:795-801.
8. Maseri A, Lanza GA. Fluorouracil-induced coronary artery spasm. Am J Med 2001; 111:326-327.
9. Cwikiel M, Eskilsson, J Wieslander JB, Stjernquist U, Albertsson M. The appearance of endothelium in small arteries after treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits. Scanning Microsc 1996; 10:805-818.
10. Porta C, Moroni M, Ferrari S, Nastasi G. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity. Neoplasma 1998; 45:81-82.
11. Hoff PM, Ansari R, Battist G, Cox J, Kocha W, Kuperminc M, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 2001; 19:2282-2292.
12. Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, et al., for the Xeloda Colorectal Cancer Study Group. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 2001; 19:4097-4106.